| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.0M | — | -40.5% |
| Cost of Revenue | $2.0M | — | -44.5% |
| Gross Profit | $2.0M | — | -36.0% |
| R&D Expense | $2.0M | — | -44.4% |
| SG&A Expense | $4.0M | — | -1.6% |
| Operating Income | -$2.0M | — | -120.0% |
| Pre-tax Income | -$3.4M | — | -215.3% |
| Income Tax | -$10K | — | -114.1% |
| Net Income | -$3.4M | — | -217.8% |
| EPS (Basic) | -$0.11 | — | -184.6% |
| EPS (Diluted) | -$0.11 | — | -200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.7M | -24.0% | -17.0% |
| Accounts Receivable | $1.2M | -6.5% | -43.7% |
| Inventory | $831K | -0.8% | +90.2% |
| Current Assets | $16.0M | -17.8% | -14.6% |
| Total Assets | $17.7M | -17.2% | -14.4% |
| Current Liabilities | $21.3M | +3.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.7M | — | -147.7% |
| Financing Cash Flow | -$1K | — | -100.0% |
| +59.8% |
| Long-term Debt | $4.5M | -51.3% | -42.0% |
| Total Liabilities | $26.5M | -2.2% | +18.8% |
| Stockholders' Equity | -$8.8M | -53.8% | -441.8% |